Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Issa

Showing results (21-30 of 209) with videos related to

Pageof 21
Sort By:
Current Opinion in Genetics & Development|April 17, 2017
The promise of epigenetic therapy: reprogramming the cancer epigenomeAndrew D Kelly, Jean-Pierre J Issa
Seminars in Hematology|July 15, 2005
Decitabine dosing schedulesHagop M Kantarjian, Jean-Pierre J Issa
Critical Reviews in Oncology/Hematology|October 7, 2006
Decitabine--bedside to benchYasuhiro Oki, Etsuko Aoki, Jean-Pierre J Issa
Epigenomes|June 25, 2025
DNA Methylation, Aging, and CancerHimani Vaidya, Jaroslav Jelinek, Jean-Pierre J Issa
FEBS Letters|December 15, 2010
Dissecting DNA hypermethylation in cancerMarcos R H Estécio, Jean-Pierre J Issa
Cold Spring Harbor Perspectives in Medicine|February 5, 2017
DNA Hypomethylating Drugs in Cancer TherapyTakahiro Sato, Jean-Pierre J Issa, Patricia Kropf
Molecular and Cellular Biology|December 17, 2002
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancerYutaka Kondo, LanLan Shen, Jean-Pierre J Issa
Cancer Biology & Therapy|October 7, 2004
Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodelingEmile M Youssef, Jean-Pierre J Issa, Reuben Lotan
Nature Reviews. Genetics|September 16, 2016
Targeting the cancer epigenome for therapyPeter A Jones, Jean-Pierre J Issa, Stephen Baylin
Cancer Letters|April 7, 2009
Histone deacetylase inhibitors as anti-neoplastic agentsNicolas Batty, Gabriel G Malouf, Jean Pierre J Issa
Pageof 21

Showing results (21-30 of 209) with videos related to

Sort By:
Pageof 21
Current Opinion in Genetics & Development|April 17, 2017
The promise of epigenetic therapy: reprogramming the cancer epigenomeAndrew D Kelly, Jean-Pierre J Issa
Seminars in Hematology|July 15, 2005
Decitabine dosing schedulesHagop M Kantarjian, Jean-Pierre J Issa
Critical Reviews in Oncology/Hematology|October 7, 2006
Decitabine--bedside to benchYasuhiro Oki, Etsuko Aoki, Jean-Pierre J Issa
Epigenomes|June 25, 2025
DNA Methylation, Aging, and CancerHimani Vaidya, Jaroslav Jelinek, Jean-Pierre J Issa
FEBS Letters|December 15, 2010
Dissecting DNA hypermethylation in cancerMarcos R H Estécio, Jean-Pierre J Issa
Cold Spring Harbor Perspectives in Medicine|February 5, 2017
DNA Hypomethylating Drugs in Cancer TherapyTakahiro Sato, Jean-Pierre J Issa, Patricia Kropf
Molecular and Cellular Biology|December 17, 2002
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancerYutaka Kondo, LanLan Shen, Jean-Pierre J Issa
Cancer Biology & Therapy|October 7, 2004
Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodelingEmile M Youssef, Jean-Pierre J Issa, Reuben Lotan
Nature Reviews. Genetics|September 16, 2016
Targeting the cancer epigenome for therapyPeter A Jones, Jean-Pierre J Issa, Stephen Baylin
Cancer Letters|April 7, 2009
Histone deacetylase inhibitors as anti-neoplastic agentsNicolas Batty, Gabriel G Malouf, Jean Pierre J Issa
Pageof 21